helmholtzeyeinstituteРоссийский офтальмологический журналRussian Ophthalmological Journal2072-00762587-5760Real time Publishers10.21516/2072-0076-2022-15-4-121-125helmholtzeyeinstitute-1110Research ArticleВ ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУFOR OPHTHALMOLOGY PRACTITIONERSCOVID-19-ассоциированный ретиноваскулит при поздней стадии ВИЧ-инфекции. Клинический случайCOVID-19-associated retinovasculitis in the late stage of HIV infection: a clinical casehttps://orcid.org/0000-0003-2071-9322ГавриловаТ. В.GavrilovaT. V.

Татьяна Валерьевна Гаврилова — член-корр. РАН, д-р мед. наук,профессор, заведующая кафедрой офтальмологии

ул. Петропавловская, д. 26, Пермь, 614990

Tatiana V. Gavrilova — Dr. of Med. Sci., professor, head of ophthalmology department

26, Petropavlovskaya St., Perm, 614990

gavrilova.tv@mail.ruhttps://orcid.org/0000-0001-8187-4081СергиенкоА. П.SergienkoA. P.

Анна Павловна Сергиенко — ассистент кафедры офтальмологии

ул. Петропавловская, д. 26, Пермь, 614990

Anna P. Sergienko — assistant professor, ophthalmology department

26, Petropavlovskaya St., Perm, 614990

https://orcid.org/0000-0002-6169-7978ЧерешневаМ. В.ChereshnevaM. V.

Маргарита Владимировна Черешнева — д-р мед. наук, профессор, главный научный сотрудник лаборатории иммунофизиологии и иммунофармакологии

ул. Первомайская, д. 106, Екатеринбург, 620041

Margarita V. Chereshneva – Dr. of Med. Sci., professor, principal researcher, laboratory of immunophysiology and immunopharmacology

106, Pervomayskaya St., Ekaterinburg, 620041

ФГБОУ ВО «Пермский государственный медицинский университет им. акад. Е.А. Вагнера» Минздрава РоссииРоссияAcademician E.A. Vagner Perm State Medical UniversityRussian FederationФГБУН «Институт иммунологии и физиологии УрО РАН»РоссияInstitute of Immunology and Physiology, Ural Branch, Russian Academy of SciencesRussian Federation202214122022154121125Copyright © Гаврилова Т.В., Сергиенко А.П., Черешнева М.В., 20222022Гаврилова Т.В., Сергиенко А.П., Черешнева М.В.Gavrilova T.V., Sergienko A.P., Chereshneva M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://roj.igb.ru/jour/article/view/1110

Описан клинический случай ретиноваскулита на фоне течения коронавирусной инфекции COVID-19 у пациентки с поздней стадией ВИЧ-инфекции, не получавшей антиретровирусную терапию. Выявлены клинические особенности глазных изменений, их степень тяжести и динамика при проводимой глазной терапии. Показана зависимость между течением COVID-19 и иммунодефицитным состоянием, связанным с поражением организма ВИЧ. В результате длительного течения болезни и развившихся осложнений наступила гибель пациентки.

A clinical case of retinovasculitis with coronavirus infection COVID-19 involving a female patient in the late stage of HIV infection is reported. The patient had no antiretroviral therapy. Clinical features of eye changes, their severity and dynamics influenced by the ophthalmic therapy were revealed. A relationship between the course of COVID-19 and the state of immunodeficiency causes by HIV was found. As a result of the long disease duration and the complications, the patient died.

COVID-19SARS-CoV-2ретиноваскулитВИЧ-инфекцияантиретровирусная терапияCOVID-19SARS-CoV-2retinovasculitisHIV infectionantiretroviral therapyReferencesGhebreyesus T.A. Breaking. World Health Organization (11 March 2020). Available at: https://www.who.int/director-general/speeches/detail/who-director-generals-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020Ghebreyesus T.A. Breaking. World Health Organization (11 March 2020). Available at: https://www.who.int/director-general/speeches/detail/who-director-generals-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020Johns Hopkins University. Coronavirus Recourse Center. Available at: https://coronavirus.jhu.edu/map.htmlJohns Hopkins University. Coronavirus Recourse Center. Available at: https://coronavirus.jhu.edu/map.htmlHuang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020; 395 (10223): 497–506. https://doi.org/10.1016/s0140-6736(20)30183-5Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020; 395 (10223): 497–506. https://doi.org/10.1016/s0140-6736(20)30183-5Abrishami M., Tohidinezhad F., Daneshvar R., et al. Ocular manifestations of hospitalized patients with COVID-19 in northeast of Iran. Ocul. Immunol. Inflamm. 2020; 28 (5): 739–44. https://doi.org/10.1080/09273948.2020.1773868Abrishami M., Tohidinezhad F., Daneshvar R., et al. Ocular manifestations of hospitalized patients with COVID-19 in northeast of Iran. Ocul. Immunol. Inflamm. 2020; 28 (5): 739–44. https://doi.org/10.1080/09273948.2020.1773868Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020; 138 (5): 575–8. doi:10.1001/jamaophthalmol.2020.1291Wu P., Duan F., Luo C., et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020; 138 (5): 575–8. doi:10.1001/jamaophthalmol.2020.1291Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; 395 (10224): e39. https://doi.org/10.1016/s0140-6736(20)30313-5Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; 395 (10224): e39. https://doi.org/10.1016/s0140-6736(20)30313-5Loon S.-C., Teoh S.C.B., Oon L.L.E., et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. https://doi.org/10.1136/bjo.2003.035931Loon S.-C., Teoh S.C.B., Oon L.L.E., et al. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004; 88 (7): 861–3. https://doi.org/10.1136/bjo.2003.035931Chen L., Liu M., Zhang Z., et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br. J. Ophthalmol. 2020; 104 (6): 748–51. https://doi.org/10.1136/bjophthalmol-2020-316304Chen L., Liu M., Zhang Z., et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br. J. Ophthalmol. 2020; 104 (6): 748–51. https://doi.org/10.1136/bjophthalmol-2020-316304Chen X., Yu H., Mei T., et al. SARS-CoV-2 on the ocular surface: is it truly a novel transmission route? Br. J. Ophthalmol. 2020; 105 (9): 1190–5. https://doi.org/10.1136/bjophthalmol-2020-316263Chen X., Yu H., Mei T., et al. SARS-CoV-2 on the ocular surface: is it truly a novel transmission route? Br. J. Ophthalmol. 2020; 105 (9): 1190–5. https://doi.org/10.1136/bjophthalmol-2020-316263Газизова И.Р., Дешева Ю.А., Гаврилова Т.В., Черешнев В.А. Распространенность конъюнктивитов у пациентов с новой коронавирусной инфекцией (COVID-19) и меры профилактики. РМЖ. Клиническая офтальмология. 2020; 20 (2): 92–6. https://doi.org/10.32364/2311-7729-2020-20-2-92-96Gazizova I.R., Desheva Yu.A., Gavrilova T.V., Chereshnev V.A. The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures. RMZh. Klinicheskaya oftal'mologiya. 2020; 20 (2): 92–6 (in Russian). https://doi.org/10.32364/2311-7729-2020-20-2-92-96Нероев В.В., Киселева Т.Н., Елисеева Е.К. Офтальмологические аспекты коронавирусной инфекции. Россий ский офтальмологический журнал. 2021; 14 (1): 7–14. https://doi.org/10.21516/2072-0076-2021-14-1-7-14Neroev V.V., Kiseleva T.N., Eliseeva E.K. Ophthalmological aspects of coronavirus infections. Russian ophthalmological journal. 2021; 14 (1): 7–14 (in Russian). https://doi.org/10.21516/2072-0076-2021-14-1-7-14Ахметшин Р.Ф., Ризванов А.А., Булгар С.Н. и др. Коронавирусная инфекция и офтальмология. Казанский медицинский журнал. 2020; 101 (3): 371–80. doi:10.17816/KMJ2020-371Akhmetshin R.F., Rizvanov A.A., Bulgar S.N., et al. Coronavirus infection and ophthalmology. Kazanskiy medizinskiy zhurnal. 2020; 101 (3): 371–80 (in Russian). doi:10.17816/KMJ2020-371Honavar S., Sen M., Sharma N., Sachdev M. COVID-19 and eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J. Ophthalmol. 2021; 69 (3): 488–509. https://doi.org/10.4103/ijo.ijo_297_21Honavar S., Sen M., Sharma N., Sachdev M. COVID-19 and eye: A Review of Ophthalmic Ma-nifestations of COVID-19. Indian J. Ophthalmol. 2021; 69 (3): 488–509. https://doi.org/10.4103/ijo.ijo_297_21Li Y.P., Ma Y., Wang N., Jin Z.B. Eyes on coronavirus. Stem Cell Res. 2021; 51: 102200. https://doi.org/10.1016/j.scr.2021.102200Li Y.P., Ma Y., Wang N., Jin Z.B. Eyes on coronavirus. Stem Cell Res. 2021; 51: 102200. https://doi.org/10.1016/j.scr.2021.102200Lani-Louzada R., Ramos C. do V.F., Cordeiro R.M., Sadun A.A. Retinal changes in COVID-19 hospitalized cases. PLoS One. 2020; 15 (12): e 0243346. https://doi.org/10.1371/journal.pone.0243346Lani-Louzada R., Ramos C. do V.F., Cordeiro R.M., Sadun A.A. Retinal changes in COVID-19 hospitalized cases. PLoS One. 2020; 15 (12): e 0243346. https://doi.org/10.1371/journal.pone.0243346Karampelas M., Dalamaga M., Karampela I. Does COVID-19 involve the retina? Ophthalmol. Ther. 2020; 9 (4): 693–5. https://doi.org/10.1007/s40123-020-00299-xKarampelas M., Dalamaga M., Karampela I. Does COVID-19 involve the retina? Ophthalmol. Ther. 2020; 9 (4): 693–5. https://doi.org/10.1007/s40123-020-00299-xSheth J., Narayanan R., Goyal J., Goyal V. Retinal vein occlusion in COVID-19: A novel entity. Indian J. Ophthalmol. 2020; 68 (10): 2291–3. https://doi.org/10.4103/ijo.ijo_2380_20Sheth J., Narayanan R., Goyal J., Goyal V. Retinal vein occlusion in COVID-19: A novel entity. Indian J. Ophthalmol. 2020; 68 (10): 2291–3. https://doi.org/10.4103/ijo.ijo_2380_20Montesel A., Bucolo C., Mouvet V., Moret E., Chiara M.E. Case report: central retinal artery occlusion in a COVID-19 Patient. Front. Pharmacol. 2020; 11: 588384. doi:10.3389/fphar.2020.588384Montesel A., Bucolo C., Mouvet V., Moret E., Chiara M.E. Case report: central retinal artery occlusion in a COVID-19 Patient. Front. Pharmacol. 2020; 11: 588384. doi:10.3389/fphar.2020.588384Pereira L.A., Soares L.C.M., Nascimento P.A., et al. Retinal findings in hospitalised patients with severe COVID-19. Br. J. Ophthalmol. 2022; 106 (1): 102–5. https://doi.org/10.1136/bjophthalmol-2020-317576Pereira L.A., Soares L.C.M., Nascimento P.A., et al. Retinal findings in hospitalised patients with severe COVID-19. Br. J. Ophthalmol. 2022; 106 (1): 102–5. https://doi.org/10.1136/bjophthalmol-2020-317576Choudhary R., Kapoor M.S., Singh A., Bodakhe S.H. Therapeutic targets of renin-angiotensin system in ocular disorders. J. Curr. Ophthalmol. 2016; 29 (1): 7–16. https://doi.org/10.1016/j.joco.2016.09.009Choudhary R., Kapoor M.S., Singh A., Bodakhe S.H. Therapeutic targets of renin-angiotensin system in ocular disorders. J. Curr. Ophthalmol. 2016; 29 (1): 7–16. https://doi.org/10.1016/j.joco.2016.09.009Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS Coronavirus. J. Virol. 2020; 94 (7): e00127-20. https://doi.org/10.1128/jvi.00127-20Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS Coronavirus. J. Virol. 2020; 94 (7): e00127-20. https://doi.org/10.1128/jvi.00127-20Sim S.S., Cheung C.M.G. Does COVID-19 infection leave a mark on the retinal vasculature? Can. J. Ophthalmol. 2021; 56 (1): 4–5. https://doi.org/10.1016/j.jcjo.2020.12.013Sim S.S., Cheung C.M.G. Does COVID-19 infection leave a mark on the retinal vasculature? Can. J. Ophthalmol. 2021; 56 (1): 4–5. https://doi.org/10.1016/j.jcjo.2020.12.013Мазус А.И., Нагибина М.В., Бессараб Т.П. и др. COVID-19/ВИЧкоинфекция: характеристика пациентов Московского мегаполиса. Терапия. 2021; 4: 18–25. https://dx.doi.org/10.18565/therapyMazus A.I., Nagibina M.V., Bessarab T.P., et al. COVID-19/HIV co-infection: characteristics of patients in the Moscow megalopolis. Terapiya. 2021; 4: 18–25 (in Russian). https://dx.doi.org/10.18565/therapyLesko C.R., Bengtson A.M. HIV and COVID-19: Intersecting epidemics with many unknowns. Am. J. Epidemiol. 2020; 190 (1): 10–6. https://doi.org/10.1093/aje/kwaa158Lesko C.R., Bengtson A.M. HIV and COVID-19: Intersecting epidemics with many unknowns. Am. J. Epidemiol. 2020; 190 (1): 10–6. https://doi.org/10.1093/aje/kwaa158Swaminathan N., Moussa P., Mody, N. Lo, K. B., Patarroyo Aponte G. COVID-19 in HIV-infected patients: A case series and literature review. J. Med. Virol. 2020; 93 (5), 2557–63. https://doi.org/10.1002/jmv.26671Swaminathan N., Moussa P., Mody, N. Lo, K. B., Patarroyo Aponte G. COVID-19 in HIV-infected patients: A case series and literature review. J. Med. Virol. 2020; 93 (5), 2557–63. https://doi.org/10.1002/jmv.26671

The authors declare that there are no conflicts of interest present.